| COP | capillary osmotic pressure; change of plaster; coefficient of performance; colloid oncotic pressure;... |
|---|---|
| CP | candle power; capillary pressure; cardiac pacing; cardiac performance; cardiopulmonary; caudate puta... |
| CPS | carbamoylphosphate synthetase; cardioplegic perfusion solution; centipoise; cervical pain syndrome; ... |
| HPCC | health plan purchasing cooperative; high performance computing and communication |
| ABC | absolute basophil count; absolute bone conduction; acalculous biliary colic; acid balance control; a... |
implicit behavior
| Tactual Performance Test | halstead-Reitan battery |
|---|---|
| employee performance appraisal | The assessment of the functioning of an employee in relation to his work. (12 Dec 1998) |
| karnofsky performance score | A measure given by a physician to a patients ability to perform certain ordinary tasks: 100-normal, no complaints, 70-unable to carry on normal activity, 50-requires considerable assistance, 40 - disabled, 30 - hospitalisation recommended. (09 Oct 1997) |
| karnofsky performance status | A performance measure for rating the ability of a person to perform usual activities, evaluating a patient's progress after a therapeutic procedure, and determining a patient's suitability for therapy. It is used most commonly in the prognosis of cancer therapy, usually after chemotherapy and customarily administered before and after therapy. It was named for dr. David a. Karnofsky, an american specialist in cancer chemotherapy. (12 Dec 1998) |
| Leiter International Performance Scale | A nonverbal (performance) test for measuring intelligence which contains norms for each age between 2 and 18; originally developed as a method of assessing the comparative intellectual abilities of Caucasian, Chinese, and Japanese children, but now occasionally used for assessing slow learners and those who are blind, deaf, or verbally handicapped. (05 Mar 2000) |
| health and human services | See HHS. (12 Dec 1998) |
| united states dept. Of health and human services | A department of the united states government concerned with administering those agencies and offices having programs pertaining to health and human services. (12 Dec 1998) |
| adenoviruses, human | Species of the genus mastadenovirus, causing a wide range of diseases in humans. Infections are mostly asymptomatic, but can be associated with diseases of the respiratory, ocular, and gastrointestinal systems. (12 Dec 1998) |
| adenovirus infections, human | Respiratory and conjunctival infections caused by 33 identified serotypes of human adenoviruses. (12 Dec 1998) |
| antigens, human platelet | Human alloantigens expressed only on platelets, specifically on platelet membrane glycoproteins. These platelet-specific antigens are immunogenic and can result in pathological reactions to transfusion therapy. (12 Dec 1998) |
| bites, human | Bites inflicted by humans. (12 Dec 1998) |
| bonding, human-pet | The emotional attachment of individuals to pets. (12 Dec 1998) |
| packed human blood cells | Whole blood from which plasma has been removed; may be prepared any time during the dating period of the whole blood from which it is derived, but not later than six days after the blood has been drawn if separation of plasma and cell's is achieved by centrifugation. (05 Mar 2000) |
| papilloma virus, human | A family of over 60 viruses responsible forcausing warts. The majority of the viruses produce warts on the hands, fingers, and even the face. most of these viruses are innocuous, causing nothing more than cosmetic concerns. Several types of HPV are confined primarily to the moist skin of the genitals, producing genital warts and elevating the risk for cancer of the cervix. These viruses that cause wartlike growths on the genitals and contrribute to cancer of the cervix are sexually transmitted. (12 Dec 1998) |
| parainfluenza virus 1, human | The type species of paramyxovirus also called haemadsorption virus 2 (ha2), which causes laryngotracheitis in humans, especially children. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|